-
to extend these approaches towards new tools and organ systems to better understand how human immune cells interact with α-synuclein pathology in the earliest events of Parkinson’s disease. Position Lead an
-
optical activity, for strong and predictable enantioselective interactions with nanoscale biological entities, such as proteins and amyloid fibrils. Three-dimensional (3D) investigation of the NPs structure
-
xenotransplantation models and supported by the Horizon Europe (ERC), we aim to extend these approaches towards new tools and organ systems to better understand how human immune cells interact with α-synuclein
-
applicable methodology to design chiral nanoparticles (NPs) with exceptional optical activity, for strong and predictable enantioselective interactions with nanoscale biological entities, such as proteins and